Enero Group (EGG) AGM 2026 presentation summary

Financial performance review

• FY26 continuing operations revenue $129.5m, down 7% YoY; EBITDA $15.3m, up 9%, with 11.8% margin, up 1.6 ppts.

• Adjusted net profit $6.4m and adjusted EPS 7.0 cents, each up 54% YoY; net cash $24.5m.

• FY27 Q1 THC Practice revenue $28.9m, down 15%; EBITDA $4.3m, down 17%, and margin 15.0% vs 15.4% in FY26 Q1.

• FY27 Q1 Group EBITDA was $2.5m, down 28% YoY; Orchard revenue grew 16% and EBITDA 38%, while Hotwire and BMF revenue fell 20% and 29%.

Board and executive committee updates

• David Brain was re-elected as a director; proxy votes were 99.41% for and 0.58% against.

• Ian Ball, CEO and Managing Director, received approval for the granting of rights, with 98.84% for and 1.16% against.

Shareholder proposals

• Shareholders considered adoption of the remuneration report; proxy votes were 99.12% for and 0.87% against.